Pancreas Disorder and Islet Transplantation

Stem cell-derived pancreatic islet transplantation is a β-cell replacement therapy which involves transplantation of isolated islets from donor pancreas to receiver, for the treatment of insulin-deficient diabetes. Once they are transplanted, the islets start producing insulin and actively regulate blood glucose levels. It was observed that 70% of patients who received an islet cell transplant no longer needs insulin after one year and may not need it in the future. Some of the benefits of Islet Transplantation are

  • Improved blood glucose levels
  • Less need or no need for insulin injections to manage diabetes
  • Fewer or no episodes of severe hypoglycaemia

Related Conference of Pancreas Disorder and Islet Transplantation

July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 27-28, 2025

5th World Congress on Endocrine and Diabetes

Madrid, Spain
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 03-04, 2025

34th European Diabetes Congress

Rome, Italy
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
November 24-25, 2025

6th International conference on Diabetic complications

Barcelona, Spain
February 23-24, 2026

19th International Summit on Diabetes

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France

Pancreas Disorder and Islet Transplantation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in